Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating coronary heart disease

A composition and technology for coronary heart disease, applied in the field of medicine, can solve the problems of slow onset, incomplete drug use, low curative effect, etc., and achieve the effects of improving compliance, comprehensive drug action, and simple preparation

Inactive Publication Date: 2016-04-06
王世喜
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the current clinical practice of traditional Chinese medicine, most of the Chinese patent medicines used in the treatment of coronary heart disease and angina pectoris have the defects of incomplete medication, low curative effect, and slow onset of effect, and often need to be used in combination with multiple drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The mixture of embodiment 1 pharmaceutical composition of the present invention

[0027] Weigh each raw material of the present invention according to the following parts by weight: 5 parts of Panax notoginseng, 6 parts of Rhizoma Chuanxiong, 14 parts of Citrus aurantium, 14 parts of Curcuma, 6 parts of Bupleurum, 10 parts of Poria, 25 parts of Scallop, 3 parts of Radix Paeoniae Alba, 4 parts of Agarwood 5 parts of kudzu root, 3 parts of clove, 6 parts of salvia miltiorrhiza.

[0028] Preparation method: Take each medicinal material with the above weight components, add water 8 times the total weight of the medicinal materials, soak for 1 hour, decoct 2 times for 1.5 hours each time, filter, combine the filtrate, and concentrate the filtrate under reduced pressure to a relative density of 1.10-1.20 The extract, the relative density is the test result at 65 degrees Celsius, add ethanol until the alcohol content is 75% (v / v), let it stand for 24h, take the supernatant, re...

Embodiment 2

[0029] The tablet of embodiment 2 pharmaceutical composition of the present invention

[0030] Weigh each raw material of the present invention according to the following parts by weight: 5 parts of Panax notoginseng, 6 parts of Rhizoma Chuanxiong, 14 parts of Citrus aurantium, 14 parts of Curcuma, 6 parts of Bupleurum, 10 parts of Poria, 25 parts of Scallop, 3 parts of Radix Paeoniae Alba, 4 parts of Agarwood 5 parts of kudzu root, 3 parts of clove, 6 parts of salvia miltiorrhiza.

[0031] Preparation method: Take each medicinal material with the above weight components, add water 8 times the total weight of the medicinal materials, soak for 1 hour, decoct 2 times for 1.5 hours each time, filter, combine the filtrate, and concentrate the filtrate under reduced pressure to a relative density of 1.10-1.20 The extractant, the relative density is the test result at 65 degrees Celsius, add ethanol until the alcohol content is 75% (v / v), let it stand for 24h, take the supernatant, ...

Embodiment 3

[0032] The capsule of embodiment 3 pharmaceutical compositions of the present invention

[0033] Weigh each raw material of the present invention according to the following parts by weight: 5 parts of Panax notoginseng, 6 parts of Rhizoma Chuanxiong, 14 parts of Citrus aurantium, 14 parts of Curcuma, 6 parts of Bupleurum, 10 parts of Poria, 25 parts of Scallop, 3 parts of Radix Paeoniae Alba, 4 parts of Agarwood 5 parts of kudzu root, 3 parts of clove, 6 parts of salvia miltiorrhiza.

[0034]Preparation method: Take each medicinal material with the above weight components, add water 8 times the total weight of the medicinal materials, soak for 1 hour, decoct 2 times for 1.5 hours each time, filter, combine the filtrate, and concentrate the filtrate under reduced pressure to a relative density of 1.10-1.20 The extract, the relative density is the test result at 65 degrees Celsius, add ethanol until the alcohol content is 75% (v / v), let it stand for 24h, take the supernatant, re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and relates to a medicinal composition, in particular to a medicinal composition for treating a coronary heart disease and application thereof to preparation of a medicament for preventing and treating the coronary heart disease. The medicinal composition for treating or preventing the coronary heart disease provided by the invention comprises the components of pseudo-ginseng, Szechuan lovage rhizome, bitter orange, turmeric root-tuber, Chinese thorowax root, poria cocos, longstamen onion bulb, white paeony root, Chinese eaglewood, kudzuvine root, clove and red-rooted salvia root. The medicinal composition has a very good effect on the aspect of treatment or prevention of the coronary heart disease, and has remarkable clinical popularization value.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating coronary heart disease and its application as a medicine for treating coronary heart disease of heart blood stasis type. Background technique [0002] The main symptoms of cardiovascular diseases are: essential hypertension, arteriosclerosis, coronary heart disease, valvular heart disease, infective endocarditis, myocardial disease (primary cardiomyopathy, specific cardiomyopathy, mountain disease), pericardial disease acute pericarditis, constrictive pericarditis, pulmonary heart disease, arteriosclerosis peripheral tube occlusion syndrome, Takayasu arteritis, thrombophlebitis, cardiac autonomic dysfunction. Main pathological conditions: heart failure, arrhythmia, angina pectoris, hypertension, etc. [0003] Coronary heart disease angina pectoris is a clinical syndrome characterized by episodic chest pain or chest discomfor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61P9/10
CPCA61K9/14A61K9/20A61K9/48A61K36/076A61K36/233A61K36/236A61K36/258A61K36/488A61K36/537A61K36/61A61K36/71A61K36/752A61K36/835A61K36/8962A61K36/9066A61K2236/331A61K2236/39A61K2300/00
Inventor 王世喜刘景妨刘景艳
Owner 王世喜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products